Soleno Therapeutics appoints Jennifer Fulk as CFO
Source: SeekingAlpha
2026-02-26 08:45:33 ET
More on Soleno Therapeutics
- Soleno Therapeutics, Inc. (SLNO) Q4 2025 Earnings Call Transcript
- Soleno Therapeutics: Why I'm Staying On The Sidelines
- Soleno targets 1,000 new VYKAT XR patient start forms in next 9–12 months while expanding into new rare disease indications
- Seeking Alpha’s Quant Rating on Soleno Therapeutics
- Historical earnings data for Soleno Therapeutics
Read the full article on Seeking Alpha
For further details see:
Soleno Therapeutics appoints Jennifer Fulk as CFO
Soleno Therapeutics Inc.
NASDAQ: SLNO
SLNO Trading
-1.82% G/L:
$39.595 Last:
428,568 Volume:
$40.27 Open:
SLNO Latest News
March 10, 2026 08:00:00 am
Soleno Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SLNO
March 09, 2026 12:48:00 pm
Rosen Law Firm Urges Soleno Therapeutics, Inc. (NASDAQ: SLNO) Stockholders to Contact the Firm for Information About Their Rights
February 26, 2026 08:00:00 am
Soleno Therapeutics Announces Retirement of James Mackaness and Appointment of Jennifer Fulk as Chief Financial Officer
SLNO Stock Data
$2,184,386,717
45,438,681
1.25%
73
N/A
Biotechnology & Life Sciences
Healthcare
US
Redwood City
